• Documents
  • Authors
  • Tables
  • Log in
  • Sign up
  • MetaCart
  • DMCA
  • Donate

CiteSeerX logo

Advanced Search Include Citations

Tools

Sorted by:
Try your query at:
Semantic Scholar Scholar Academic
Google Bing DBLP
Results 1 - 10 of 31,214
Next 10 →

On the mechanics of economic development

by X. Lucas, A. Agut, G. Ramis, E. Belda, M. Soler, X. Lucas, Hospital Departmenit Of, G. Ramis, Ininovation Departmenit, Cefu Sa - Journal of Monetary Economics , 1988
"... THERE have been very few reports of uterine rupture in the cat in the literature (Webb 1972). The causes include external trauma during pregnancy, severe alterations of the wall of the uterus, inadequate obstetric manipulations, and the incorrect use of drugs such as oxytocin or prostaglandin F2ec ( ..."
Abstract - Cited by 3847 (7 self) - Add to MetaCart
THERE have been very few reports of uterine rupture in the cat in the literature (Webb 1972). The causes include external trauma during pregnancy, severe alterations of the wall of the uterus, inadequate obstetric manipulations, and the incorrect use of drugs such as oxytocin or prostaglandin F2ec

Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: Implications for substance abuse prevention

by J. David Hawkins, Richard E Catalano, Janet Y Miller - Psychological Bulletin , 1992
"... The authors suggest that the most promising route to effective strategies for the prevention of adolescent alcohol and other drug problems is through a risk-focused approach. This approach requires the identification of risk factors for drug abuse, identification of methods by which risk factors hav ..."
Abstract - Cited by 725 (18 self) - Add to MetaCart
, Ferguson, & Kopstein, 1990). The consequences of drug abuse are acute on both a personal and a societal level. For the developing young adult, drug and alcohol abuse under-mines motivation, interferes with cognitive processes, contrib-

Predictive reward signal of dopamine neurons

by Wolfram Schultz - Journal of Neurophysiology , 1998
"... Schultz, Wolfram. Predictive reward signal of dopamine neurons. is called rewards, which elicit and reinforce approach behav-J. Neurophysiol. 80: 1–27, 1998. The effects of lesions, receptor ior. The functions of rewards were developed further during blocking, electrical self-stimulation, and drugs ..."
Abstract - Cited by 747 (12 self) - Add to MetaCart
Schultz, Wolfram. Predictive reward signal of dopamine neurons. is called rewards, which elicit and reinforce approach behav-J. Neurophysiol. 80: 1–27, 1998. The effects of lesions, receptor ior. The functions of rewards were developed further during blocking, electrical self-stimulation, and drugs

Gene selection for cancer classification using support vector machines

by Isabelle Guyon, Jason Weston, Stephen Barnhill, Vladimir Vapnik, Nello Cristianini - Machine Learning
"... Abstract. DNA micro-arrays now permit scientists to screen thousands of genes simultaneously and determine whether those genes are active, hyperactive or silent in normal or cancerous tissue. Because these new micro-array devices generate bewildering amounts of raw data, new analytical methods must ..."
Abstract - Cited by 1115 (24 self) - Add to MetaCart
be developed to sort out whether cancer tissues have distinctive signatures of gene expression over normal tissues or other types of cancer tissues. In this paper, we address the problem of selection of a small subset of genes from broad patterns of gene expression data, recorded on DNA micro-arrays. Using

Embryonic stem cell lines derived from human blastocysts

by James A. Thomson, Joseph Itskovitz-eldor, Er S. Shapiro, Michelle A. Waknitz, Jennifer J. Swiergiel, Vivienne S. Marshall, Jeffrey M. Jones - Tissue Engineering For Peer Review , 1998
"... Human blastocyst-derived, pluripotent cell lines are described that have normal karyotypes, express high levels of telomerase activity, and express cell surface markers that characterize primate embryonic stem cells but do not characterize other early lineages. After undifferentiated proliferation i ..."
Abstract - Cited by 470 (6 self) - Add to MetaCart
, and stratiÞed squamous epithelium (ectoderm). These cell lines should be useful in human develop-mental biology, drug discovery, and transplantation medicine. Embryonic stem (ES) cells are derived from totipotent cells of the early mamma-lian embryo and are capable of unlimited, undifferentiated proliferation

Molecular targets for antiepileptic drug development

by Brian S. Meldrum, Brian S. Meldrum, Michael A. Rogawski - Neurotherapeutics , 2007
"... Molecular targets for antiepileptic drug development ..."
Abstract - Cited by 11 (1 self) - Add to MetaCart
Molecular targets for antiepileptic drug development

for drug development

by Daniel K. Borger, Ellen Sidransky, Elma Aflaki, Correspondence Ellen Sidransky , 2015
"... New macrophage models of Gaucher disease offer new tools ..."
Abstract - Add to MetaCart
New macrophage models of Gaucher disease offer new tools

Drug Development

by P Y Han, I D Coombes, B Green , 2004
"... uq.edu.au Accepted for publication ..."
Abstract - Add to MetaCart
uq.edu.au Accepted for publication

in Drug Development.

by Kannan Natarajan, Neal Thomas, Demissie Alemayehu, Z. Gary Ge, Robert A. Smith, Ralph H. Raymond, Foot Overview Of Population
"... ..."
Abstract - Add to MetaCart
Abstract not found

Spending on new drug development

by Christopher P. Adams, Van V. Brantner - Health Economics , 2010
"... This paper replicates DiMasi et al (2003, 2004) estimates of expenditure on new drug development using publicly available data. The paper estimates that average expenditure on drugs in human clinical trials is around $25m per year, with $18m per year on drugs in Phase 1, $33m on drugs in Phase 2 and ..."
Abstract - Cited by 7 (0 self) - Add to MetaCart
This paper replicates DiMasi et al (2003, 2004) estimates of expenditure on new drug development using publicly available data. The paper estimates that average expenditure on drugs in human clinical trials is around $25m per year, with $18m per year on drugs in Phase 1, $33m on drugs in Phase 2
Next 10 →
Results 1 - 10 of 31,214
Powered by: Apache Solr
  • About CiteSeerX
  • Submit and Index Documents
  • Privacy Policy
  • Help
  • Data
  • Source
  • Contact Us

Developed at and hosted by The College of Information Sciences and Technology

© 2007-2019 The Pennsylvania State University